Systematic review of approaches to informed consent in recent high-impact clinical trials
{{output}}
The U.S. Food and Drug Administration (FDA) recently harmonized its regulatory criteria for waivers and alterations of informed consent with the U.S. Common Rule. We conducted a systematic review of clinical trials in the two highest-impact clinical journals i... ...
